Progress toward the development of a vaccine to prevent Moraxella (Branhamella) catarrhalis infections

Microbes and Infection

Volumn 2, Issue 5, 2000, Pages 561-568

  McMichael, John C ^a  

^a PFIZER INC   (United States)

Author keywords

Chronic obstructive pulmonary disease; Otitis media; Vaccine

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL VACCINE; BACTERIUM LIPOPOLYSACCHARIDE; BINDING PROTEIN; CD PROTEIN; COPB PROTEIN; E PROTEIN; HEMAGGLUTININ; LACTOFERRIN; LACTOFERRIN BINDING PROTEIN; OLIGOSACCHARIDE; OUTER MEMBRANE PROTEIN; PROTEIN 200K; TRANSFERRIN; TRANSFERRIN BINDING PROTEIN; UNCLASSIFIED DRUG; USPA PROTEIN;

BACTERIAL GENE; BACTERIAL OUTER MEMBRANE; BACTERIAL VIRULENCE; CHRONIC OBSTRUCTIVE LUNG DISEASE; GRAM NEGATIVE INFECTION; MORAXELLA CATARRHALIS; NONHUMAN; OTITIS MEDIA; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; REVIEW; VACCINE PRODUCTION;

BACTERIA (MICROORGANISMS); MORAXELLA CATARRHALIS; NEGIBACTERIA;

EID: 0034041134     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(00)00310-5     Document Type: Review

References (61)

1. Catlin B.W. Branhamella catarrhalis: an organism gaining respect as a pathogen. Clin. Micro. Rev. 3:1990;293-320.
2. Murphy T.F. Branhamella catarrhalis: epidemiology, surface antigenic structure, and immune response. Microbiol. Rev. 60:1996;267-279.
3. Christensen J.J. Moraxella (Branhamella) catarrhalis: clinical, microbiological and immunological features in lower respiratory tract infections. APMIS. 107S:1999;1-36.
4. Ahmed K., Rikitomi N., Ichinose A., Matsumoto K. Possible presence of a capsule in Branhamella catarrhalis. Microb. Immunol. 35:1991;361-366.
5. Wistreich G.A., Baker R.F. The presence of fimbriae (pili) in three species of Neisseria. J. Gen. Microbiol. 65:1971;167-173.
6. Kyd J.M., Cripps A.W. Killed whole bacterial cells, a mucosal delivery system for the induction of immunity in the respiratory tract and middle ear: an overview. Vaccine. 17:1999;1775-1781.
7. Takada R., Harabuchi Y., Himi T., Kataura A. Antibodies specific to outer membrane antigens of Moraxella catarrhalis in sera and middle ear effusions from children with otitis media with effusion. Int. J. Ped. Otorhinolaryngol. 46:1998;185-195.
8. Goldblatt D., Scadding G.K., Lund V.J., Wade A.M., Turner M.W., Pandey J.P. Association of Gm allotypes with the antibody response to the outer membrane proteins of a common upper respiratory tract organism, Moraxella catarrhalis. J. Immunol. 153:1994;5316-5320.
9. Chen D., Barniak V., Vandermeid K.R., McMichael J.C. The levels and bactericidal capacity of antibodies directed against the UspA1 and UspA2 outer membrane proteins of Moraxella (Branhamella) catarrhalis in adults and children. Infect. Immun. 67:1999;1310-1316.
10. Robbins J.B., Schneerson R., Szu S.S. Perspective: hypothesis: serum IgG antibody is sufficient to confer protection against infectious diseases by inactivating the inoculum. J. Infect. Dis. 171:1995;1387-1398.
11. Vandewoude S.J., Luzarraga M.B. The Role ofBranhamella catarrhalis in the "Bloody Nose Syndrome" of Cynomologus Macaques. Lab. Anim. Sci. 41:1991;401-406.
12. Chung M.H., Enrique R., Lim D.J., Demaria T.F. Moraxella (Branhamella) catarrhalis-induced experimental otitis media in the chinchilla. Acta Oto Laryngol. 114:1994;415-422.
13. Unhanand M., Maciver I., Ramilo O., Arencibia-Mireles O., Argyle J.C., McCracken G.H., Hansen E.J. Pulmonary clearance of Moraxella catarrhalis in an animal model. J. Infect. Dis. 165:1992;644-650.
14. Winsnes R., Lonnes T., Mogster B., Berdal B.P. Antibody responses after vaccination and disease against leukocytosis promoting factor, filamentous hemagglutinin, lipopolysaccharide and a protein binding to complement-fixing antibodies induce during whooping cough. Develop. Biol. Stand. 61:1985;353-365.
15. Noel G.J., Katz S., Edelson P.J. Complement-mediated early clearance of Haemophilus influenzae type b from blood is independent of serum lytic activity. J. Infect. Dis. 157:1988;85-90.
16. Fitzgerald M., Mulcahy R., Murphy S., Keane C., Coakley D., Scott T. A 200 kDa protein is associated with haemagglutinating isolates of Moraxella (Branhamella) catarrhalis. FEMS Immun. Med. Microbiol. 18:1997;209-216.
17. Tucker K., Plosila L., Samuel J. Correlation between hemagglutination and globotetraosylceramide binding by Branhamella catarrhalis. Abstracts of the 94th General Meeting of the American Society for Microbiology. 1994;117.
18. Murphy S., Fitzgerald M., Mulcahy R., Keane C., Coakley D., Scott T. Studies on haemagglutination and serum resistance status of strains of Moraxella catarrhalis isolated from the elderly. Gerontology. 43:1997;277-282.
19. McMichael J.C., Fiske M.J., Fredenburg R.A., Chakravarti D.N., Vandermeid K.R., Barniak V., Caplan J., Bortell E., Baker S., Arumugham R., Chen D. Isolation and characterization of two proteins from Moraxella catarrhalis that bear a common epitope. Infect. Immun. 66:1998;4374-4381.
20. Cope L.D., Lafontaine E.R., Slaughter C.A., Hasemann C.A., Aebi C., Henderson F.W., McCracken G.H., Hansen E.J. Characterization of the Moraxella catarrhalis UspA1 and UspA2 genes and their encoded products. J. Bacteriol. 181:1999;4026-4034.
21. Aebi C., Lafontaine E.R., Cope L.D., Latimer J.L., Lumbley S.L., McCracken G.H., Hansen E.J. Phenotypic effect of isogenic uspA1 and uspA2 mutations on Moraxella catarrhalis strain O35E. Infect. Immun. 66:1998;3113-3119.
22. Helminen M.E., Maciver I., Latimer J.L., Klesney-Tait J., Cope L.D., Paris M., McCracken G.H., Hansen E.J. A large, antigenically conserved protein on the surface of Moraxella catarrhalis is a target for protective antibodies. J. Infect. Dis. 170:1994;867-872.
23. Murphy T.F., Loeb M.R. Isolation of the outer membrane of Branhamella catarrhalis. Microb. Pathogen. 6:1989;159-174.
24. De Mot R., Vanderleyden J. A conserved surface-exposed domain in major outer membrane proteins of pathogenic Pseudomonas and Branhamella species shares sequence homology with the calcium-binding repeats of the eukaryotic extracellular matrix protein thrombospondin. Mol. Microbiol. 13:1994;379-380.
25. Reddy M.S., Murphy T.F., Faden H.S., Bernstein J.M. Middle ear mucin glycoprotein: purification and interaction with nontypeable Haemophilus influenzae and Moraxella catarrhalis. Otolaryngol. Head Neck Surg. 116:1997;175-180.
26. Miyamoto N., Bakeletz L.O. Kinetics of the ascension of NTHi from the nasopharynx to the middle ear coincident with adenovirus-induced compromise in the chinchilla. Microb. Pathol. 23:1997;119-126.
27. Sarwar J., Campagnari A.A., Kirkham C., Murphy T.F. Characterization of an antigenically conserved heat-modifiable major outer membrane protein of Branhamella catarrhalis. Infect. Immun. 60:1992;804-809.
28. Murphy T.F., Kirkham C., Lesse A.J. The major heat-modifiable outer membrane protein CD is highly conserved among strains of Branhamella catarrhalis. Mol. Microbiol. 10:1993;87-97.
29. Murphy T.F., Kyd J.M., John A., Kirkham C., Cripps A.W. Enhancement of pulmonary clearance of Moraxella (Branhamella) catarrhalis following immunization with outer membrane protein CD in a mouse model. J. Infect. Dis. 178:1998;1667-1675.
30. Yang Y.P., Myers L.E., McGuinness U., Chong P., Kwok Y., Klein M.H., Harkness R.E. The major outer membrane protein, CD, extracted from Moraxella (Branhamella) catarrhalis is a potential vaccine antigen that induces bactericidal antibodies. FEMS Immunol. Med. Microbiol. 17:1997;187-199.
31. Bonnah R.A., Yu R.H., Wong H., Schryvers A.B. Biochemical and immunological properties of lactoferrin binding proteins from Moraxella (Branhamella) catarrhalis. Microb. Pathog. 24:1998;89-100.
32. Maluszynska G.M., Kraachler B., Sundqvist T. The ability to bind albumin is correlated with nitric oxide sensitivity in Moraxella catarrhalis. FEMS Microbiol. Lett. 166:1998;249-255.
33. Yu R.H., Bonnah R.A., Ainsworth S., Schryvers A.B. Analysis of the immunological responses to transferrin and lactoferrin receptor proteins from Moraxella catarrhalis. Infect. Immun. 67:1999;3793-3799.
34. Mathers K.E., Goldblatt D., Aebi C., Yu R.H., Schryvers A.B., Hansen E.J. Characterization of an outer membrane protein of Moraxella catarrhalis. FEMS Immunol. Med. Microbiol. 19:1997;231-236.
35. Campagnari A.A., Ducey T.F., Rebmann C.A. Outer membrane protein B1, an iron-repressible protein conserved in the outer membrane of Moraxella (Branhamella) catarrhalis, binds human transferrin. Infect. Immun. 64:1996;3920-3924.
36. Chen D., McMichael J.C., Van Der Meid K.R., Masi A.W., Bortell E., Caplan J.D., Chakravarti D., Barniak V.L. Evaluation of a 74-kDa transferrin binding protein from Moraxella (Branhamella) catarrhalis as a vaccine candidate. Vaccine. 18:1999;109-118.
37. Ala'aldeen D.A.A. Transferrin receptors of Neisseria meningitidis: promising candidates for a broadly cross-protective vaccine. J. Med. Microbiol. 44:1996;237-243.
38. Myers L.E., Yang Y.P., Du R.P., Wang Q., Harkness R.E., Schryvers A.B., Klein M.H., Loosmoore S.M. The transferrin binding protein B of Moraxella catarrhalis elicits bactericidal antibodies and is a potential vaccine antigen. Infect. Immun. 66:1998;4183-4192.
39. Luke N.R., Russo T.A., Luther N., Campagnari A.A. Use of an isogenic mutant constructed in Moraxella catarrhalis to identify a protective epitope of outer membrane protein B1 defined by monoclonal antibody 11C6. Infect. Immun. 67:1999;681-687.
40. Aebi C., Stone B., Beucher M., Cope L.D., Maciver I., Thomas S.E., McCracken G.H., Sparling P.F., Hansen E.J. Expression of the CopB outer membrane protein by Moraxella catarrhalis is regulated by iron and affects iron acquisition from transferrin and lactoferrin. Infect. Immun. 64:1996;2024-2030.
41. Campagnari A.A., Shanks K.L., Dyer S.A. Growth of Moraxella catarrhalis with human transferrin and lactoferrin: expression of iron-repressible proteins without siderophore production. Infect. Immun. 62:1994;4909-4914.
42. Aebi C., Cope L.D., Latimer J.L., Thomas S.E., Slaughter C.A., McCracken G.H., Hansen E.J. Mapping of a protective epitope of the CopB outer membrane protein of Moraxella catarrhalis. Infect. Immun. 66:1998;540-548.
43. Sethi S., Surface J.M., Murphy T.F. Antigenic heterogeneity and molecular analysis of CopB of Moraxella (Branhamella) catarrhalis. Infect. Immun. 65:1997;3666-3671.
44. Helminen M.E., Maciver I., Latimer J.L., Cope L.D., McCracken G.H., Hansen E.J. A major outer membrane protein of Moraxella catarrhalis is a target for antibodies that enhance pulmonary clearance of the pathogen in an animal model. Infect. Immun. 61:1993;2003-2010.
45. Bhushan R., Craigie R., Murphy T.F. Molecular cloning and characterization of outer membrane protein E of Moraxella (Branhamella) catarrhalis. J. Bacteriol. 176:1994;6636-6643.
46. Brauer A.L., Kirkham C., McNamara E.R., Murphy T.F. Sequence conservation and stability of outer membrane protein E of Moraxella catarrhalis recovered from the human respiratory tract. Abstracts of the 99th General Meeting of the American Society for Microbiology. 1999;265.
47. Oishi K., Tanaka H., Sonoda F., Borann S., Ahmed K., Utsunomiya Y., Watanbe K., Nagatake T., Vaneechoutte M., Verschraegen G., Matsumoto K. A monoclonal antibody reactive with a common epitope of Moraxella (Branhamella) catarrhalis lipopolysaccharides. Clin. Diagn. Lab. Immunol. 3:1996;351-354.
48. Rahman M., Jonsson A.B., Holme T. Monoclonal antibodies to the epitope alpha-Gal-(1-4)-beta-Gal-(1- of Moraxella catarrhalis LPS react with a similar epitope in type IV pili of Neisseria meningitidis. Microb. Pathog. 24:1998;299-308.
49. Rahman M., Holme T. Antibody response in rabbits to serotype-specific determinants in lipopolysaccharides from Moraxella catarrhalis. J. Med. Microbiol. 44:1996;348-354.
50. Vaneechoutte M., Verschraegen G., Claeys G., Abeele A.M.D. Serological typing of Branhamella catarrhalis strains on the basis of lipopolysaccharide antigens. J. Clin. Microbiol. 28:1990;182-187.
51. Holme T., Rahman M., Jansson R.E., Widmalm G. The lipopolysaccharide of Moraxella catarrhalis. Structural relationships and antigenic properties. Eur. J. Biochem. 265:1999;524-529.
52. Gu X.X., Chen J., Barenkamp S.J., Robbins J.B., Tsai C.M., Lim D.J., Battey J. Synthesis and characterization of lipooligosaccharide-based conjugates as vaccine candidates for Moraxella (Branhamella) catarrhalis. Infect. Immun. 66:1998;1891-1897.
53. Sasaki K., Harkness R.E., Loosmoore S.M., Klein M.H. Nucleic acids encoding high molecular weight major outer membrane protein of Moraxella. United States Patent 5, 808, 024. 1998.
54. Sasaki K., Myers L., Loosmore S.M., Klein M.H. Control mechanism of the 200 kD protein gene expression in Moraxella (Branhamella) catarrhalis. Abstracts of the 99th General Meeting of the American Society for Microbiology. 1999;89.
55. Rice P.A., Vayo H.E., Tam M.R., Blake M.S. Immunoglobulin G antibodies directed against protein III block killing of serum-resistant Neisseria gonorrhoeae by immune serum. J. Exp. M. 164:1986;1735-1748.
56. Hoffmann E.M., Houle J.J. Contradictory roles for antibody and complement in the interaction of Brucella abortus with its host. Crit. Rev. Microbiol. 21:1995;153-163.
57. Vandermeid K.R., Baker S.M., McMichael J.C. An isolate of Moraxella catarrhalis undergoes variation in colony morphology and expression of UspA2. Abstracts of the 99th General Meeting of the American Society for Microbiology. 1999;265.
58. Fitzgerald M., Murphy S., Mulcahy R., Keane C., Coakley D., Scott T. Tissue culture adherence and haemagglutination characteristics of Moraxella (Branhamella) catarrhalis. FEMS Immunol. Med. Microbiol. 24:1999;105-114.
59. Tucker K., Plosila L. Moraxella catarrhalis outer membrane protein-106 polypeptide, gene sequence and uses thereof. Patent application WO9741731. 1997.
60. Du R.P., Wang Q., Yang Y.P., Schryvers A.B., Chong P., Klein M.H., Loosmore S.M. Cloning and expression of the Moraxella catarrhalis lactoferrin receptor genes. Infect. Immun. 66:1998;3656-3665.
61. Aebi C., Maciver I., Latimer J.L., Cope L.D., Stevens M.K., Thomas S.E., McCracken G.H., Hansen E.J. A protective epitope of Moraxella catarrhalis is encoded by two different genes. Infect. Immun. 65:1997;4367-4377.